.png)
Certification Date: December 28, 2022
Organization: Networking Technology, Inc. dba RXNT
Product Name: RXNT Electronic Health Records
Version: 7.2
Product Certification ID: 15.04.04.2046.RxNT.72.01.1.221228
CHPL Product Number: 15.04.04.2046.RxNT.72.01.1.221228
Product Classification: Ambulatory
Additional Software: RosettaHealth HISPDirect
Pricing Transparency
Annual or monthly recurring licensing fees include all certified modules with the exception of electronic prescribing of controlled substances and direct email which are available as add-on annual or monthly recurring fees. Practices have the option to streamline immunization registry reporting for a nominal fee. For a detailed explanation of costs, click here.
Real World Testing
2022 Real World Test Plan: Click here to open PDF
2022 Real World Test Results: Click here to open PDF
2023 Real World Test Plan: Click here to open PDF
2023 Real World Test Results: Click here to open PDF
2024 Real World Test Plan: Click here to open PDF
2024 Real World Test Results: Click here to open PDF
2025 Real World Test Plan: Click here to open PDF
2025 Real World Test Results: Available in 2026
Tested and Certified Modules
Certification Criteria:
|
170.315 (a)(1): Computerized Provider Order Entry (CPOE) - Medications |
170.315(b)(11): Decision support interventions |
170.315 (d)(9): Trusted connection |
170.315 (g)(6): Consolidated CDA Creation Performance |
|
170.315 (a)(2): CPOE - Laboratory |
170.315 (c)(1): Clinical quality measures - report and export |
170.315 (d)(12): Encrypt Authentication Credentials |
170.315 (g)(7): Application access - patient selection |
|
170.315 (a)(3): CPOE - Diagnostic Imaging |
170.315 (c)(3): Clinical Quality Measures - Report |
170.315 (d)(13): Multi-Factor Authentication MFA Documentation |
170.315 (g)(9): Application Access - All Data Request |
|
170.315 (a)(4): Drug-Drug, Drug-Allergy Interaction Checks for CPOE |
170.315 (d)(1): Authentication, Access Control, Authorization |
170.315 (e)(1): View, Download, and Transmit to 3rd Party |
170.315 (h)(1): Direct Project |
|
170.315 (a)(5): Demographics |
170.315 (d)(2): Auditable Events and Tamper-Resistance |
170.315 (e)(3): Patient health information capture |
|
|
170.315 (a)(12): Family health history |
170.315 (d)(3): Audit Report(s) |
170.315 (f)(1): Transmission to Immunization registries |
|
|
170.315 (a)(14): Implantable Device List |
170.315 (d)(4): Amendments |
170.315(f)(5): Transmission to public health agencies - electronic case reporting |
|
|
170.315 (b)(1): Transitions of Care |
170.315 (d)(5): Automatic Access Time-out |
170.315 (g)(2): Automated measure calculation |
|
|
170.315 (b)(2): Clinical Information Reconciliation and Incorporation |
170.315 (d)(6): Emergency access |
170.315 (g)(3): Safety-enhanced design |
|
|
170.315 (b)(3): Electronic Prescribing |
170.315 (d)(7): End-user device encryption |
170.315 (g)(4): Quality management system |
|
|
170.315(b)(10): Electronic Health Information export |
170.315 (d)(8): Integrity |
170.315 (g)(5): Accessibility-centered design |
|
| Version | Quality Measure |
| v6 | CMS147: Preventive Care and Screening: Influenza Immunization |
| v6 | CMS68: Documentation of Current Medications in the Medical Record |
| v5 | CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
| v5 | CMS117: Childhood Immunization Status |
| v5 | CMS127: Pneumococcal Vaccination Status for Older Adults |
| v6 | CMS136: ADHD: Follow-Up Care for Children Prescribed AttentionDeficit/Hyperactivity Disorder (ADHD) Medication |
| v5 | CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
| v5 | CMS153: Chlamydia Screening for Women |
| v5 | CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents |
This Health IT Module is compliant with the ONC Certification Criteria for Health IT and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.
For more information about RXNT's ONC Certification click here.
